These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 32945146)

  • 21. Metformin enhances doxorubicin sensitivity via inhibition of doxorubicin efflux in P-gp-overexpressing MCF-7 cells.
    Shafiei-Irannejad V; Samadi N; Yousefi B; Salehi R; Velaei K; Zarghami N
    Chem Biol Drug Des; 2018 Jan; 91(1):269-276. PubMed ID: 28782285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Folate-Targeted Redox-Responsive Polymersomes Loaded with Chemotherapeutic Drugs and Tariquidar to Overcome Drug Resistance.
    Qin Y; Zhang Z; Huang C; Fan F; Liu L; Lu L; Wang H; Liu Z; Yang J; Wang C; Yang H; Sun H; Leng X; Kong D; Zhang L; Zhu D
    J Biomed Nanotechnol; 2018 Oct; 14(10):1705-1718. PubMed ID: 30041718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin.
    Zong L; Cheng G; Liu S; Pi Z; Liu Z; Song F
    J Pharm Biomed Anal; 2019 Feb; 165():268-275. PubMed ID: 30572191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversing Multidrug Resistance by Multiplexed Gene Silencing for Enhanced Breast Cancer Chemotherapy.
    Li Y; Gao X; Yu Z; Liu B; Pan W; Li N; Tang B
    ACS Appl Mater Interfaces; 2018 May; 10(18):15461-15466. PubMed ID: 29663807
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells.
    Fu LW; Zhang YM; Liang YJ; Yang XP; Pan QC
    Eur J Cancer; 2002 Feb; 38(3):418-26. PubMed ID: 11818209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitric Oxide Stimulated Programmable Drug Release of Nanosystem for Multidrug Resistance Cancer Therapy.
    Wang L; Chang Y; Feng Y; Li X; Cheng Y; Jian H; Ma X; Zheng R; Wu X; Xu K; Zhang H
    Nano Lett; 2019 Oct; 19(10):6800-6811. PubMed ID: 31466437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-gp Inhibition and Mitochondrial Impairment by Dual-Functional Nanostructure Based on Vitamin E Derivatives To Overcome Multidrug Resistance.
    Tuguntaev RG; Chen S; Eltahan AS; Mozhi A; Jin S; Zhang J; Li C; Wang PC; Liang XJ
    ACS Appl Mater Interfaces; 2017 May; 9(20):16900-16912. PubMed ID: 28463476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect.
    Chen M; Wang L; Wang F; Li F; Xia W; Gu H; Chen Y
    Int J Nanomedicine; 2019; 14():3557-3569. PubMed ID: 31190812
    [No Abstract]   [Full Text] [Related]  

  • 30. Rational Design of Metal Organic Framework Nanocarrier-Based Codelivery System of Doxorubicin Hydrochloride/Verapamil Hydrochloride for Overcoming Multidrug Resistance with Efficient Targeted Cancer Therapy.
    Zhang H; Jiang W; Liu R; Zhang J; Zhang D; Li Z; Luan Y
    ACS Appl Mater Interfaces; 2017 Jun; 9(23):19687-19697. PubMed ID: 28530401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theranostic Nanoprobe Mediated Simultaneous Monitoring and Inhibition of P-Glycoprotein Potentiating Multidrug-Resistant Cancer Therapy.
    Wei Y; Xia H; Zhang F; Wang K; Luo P; Wu Y; Liu S
    Anal Chem; 2019 Sep; 91(17):11200-11208. PubMed ID: 31403276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequential therapy with redox-responsive glucolipid nanocarrier separately delivering siRNA and doxorubicin to overcome multidrug resistance.
    Meng T; Lu B; Shao S; Yuan M; Liu X; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Dec; 534(1-2):368-377. PubMed ID: 29051118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of inhibition of P-glycoprotein mediated efflux by Pluronic P123/F127 block copolymers: relationship between copolymer concentration and inhibitory activity.
    Wei Z; Yuan S; Hao J; Fang X
    Eur J Pharm Biopharm; 2013 Feb; 83(2):266-74. PubMed ID: 23089310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alisol F 24 Acetate Enhances Chemosensitivity and Apoptosis of MCF-7/DOX Cells by Inhibiting P-Glycoprotein-Mediated Drug Efflux.
    Pan G; Li T; Zeng Q; Wang X; Zhu Y
    Molecules; 2016 Feb; 21(2):. PubMed ID: 26861264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.
    Huang IP; Sun SP; Cheng SH; Lee CH; Wu CY; Yang CS; Lo LW; Lai YK
    Mol Cancer Ther; 2011 May; 10(5):761-9. PubMed ID: 21411714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. All-in-one nanosponge with pluronic shell for synergistic anticancer therapy through effectively overcoming multidrug resistance in cancer.
    Lee JS; Hwang Y; Oh H; Sung D; Tae G; Choi WI
    Nanomedicine; 2022 Feb; 40():102486. PubMed ID: 34748960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells.
    Li C; Guan X; Xue H; Wang P; Wang M; Gai X
    Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
    Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
    Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel virosecurinine bivalent mimetics as potent reversal agents against P-glycoprotein-mediated multidrug resistance.
    Hou W; Meng Y; Xu XF; Huang ZX; Liu J; Wang ZY; Lin J; Chen WM
    Eur J Med Chem; 2019 Dec; 183():111726. PubMed ID: 31585275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.